News and Updates
Current News
New model predicts liver cancer risk in hepatitis B patients without cirrhosis
Combination strategies in advanced hepatocellular carcinoma: the CARES-310 trial
Role of Imaging in Screening for Hepatocellular Carcinoma
Aspirin Use and Risk of Hepatocellular Carcinoma in Hepatitis B
USP26: Key Driver in HBV-Induced Liver Cancer
Lucy Mathew, NP: The Importance of Liver Cancer Screening, Barriers to Surveillance
Resection Surgery Leads to Improved Liver Cancer Survival
Development and validation of a biomarker index for HCC treatment response
New Tool Could Spot Liver Cancer Early, Upping Survival
Investigating Hepatitis B Virus-Related Hepatocellular Carcinoma Incidence
Hepatocellular carcinoma immune microenvironment and check point inhibitors-current status
UAB Medicine Podcast: Multi-Disciplinary Hepatocellular Carcinoma Clinic (HCC)
Insights into Hepatocellular Carcinoma: From Pathophysiology to Novel Therapies
FPU2023- Targeting the microenvironment in liver cancer
Old Vaccine Potentially Treats Liver Cancer
Telomerase-related advances in hepatocellular carcinoma: A bibliometric and visual analysis
Adding Immunotherapy to Local Treatment Delays Liver Cancer Progression
RALDH1 Inhibition Shows Immunotherapeutic Efficacy in Hepatocellular Carcinoma
Development of pre-clinical murine models for fibrolamellar hepatocellular carcinoma
A Review of Incidence and Related Risk Factors in the Development of Hepatocellular Carcinoma
Q&A: Causes of hepatocellular carcinoma ‘differ remarkably’ by race, ethnicity
Dr Kurz on Social Determinants of Health That Contribute to Disparities in Cancer Care
News Archive
What to Know About Late-Stage Liver Cancer as a Black Person
A Guide to the Stages of Liver Cancer
Neoadjuvant Nivolumab/Ipilimumab Combo Elicits Responses, Safety in Resectable HCC
Clinical manifestation, staging and prognosis of hepatocellular carcinoma in Gambian patients
NCCN 2023 Liver Cancer Guidelines for Patients
Gene mutations linked to drug-resistant liver cancer
Complementary and Alternative Medicine
Management of Hepatocellular Carcinoma
Advancing the Care of Advanced HCC – A Hepatologist’s Perspective
Novel Use of Artificial Intelligence Shows Promise to Improve HCC Detection
Molecular and Clinical Features of Hepatocellular Carcinoma in Patients with HBV-HDV Infection
Review of insights into the success and failure of systemic therapy for liver cancer
REACH-B Score for Hepatocellular Carcinoma
About Herbs, Botanicals, and Other Products (from Memorial Sloan Kettering Cancer Center)
Four Liver Cancer Treatment Advances
Assessing the Risk of HCC for Hepatitis B Treatments
Study Uncovers New Treatment Approaches for Liver Cancer Patients
NUS Scientists Discover New Clues to Liver Cancer Progression
Cancer survivors: Managing your emotions after cancer treatment
Researchers Identify a New tsRNA in Blood to Improve Liver Cancer Diagnosis
Case 3: Novel Frontline Combination Strategies for Unresectable HCC (Video)
What Gastroenterologists Need to Know About New Guidelines on Systemic HCC Therapy
Bringing Early Cancer Detection to the Masses
What Cancer Survivors Should Know About Their Mental Health
Evidence Grows for Avoiding Biopsy in Hepatocellular Carcinoma
New Guidelines Clarify Use of Systemic Therapy in Advanced HCC
COVID-19: What People With Cancer Need to Know (Cancer.net, June 2020)
Atezolizumab Combination Improves Survival in HCC (Cancer Letter, May 2020)
New Point-of-Care Ultrasound Tool May Aid Detection of Liver Stiffness in Obese Patients
Phase II Trial of GT90001 Plus Nivolumab Enrolls First Patient with Advanced HCC
Treatment of Hepatocellular Carcinoma in Sub-Saharan Africa: Challenges and Solutions
Kintor Initiates Dosing in Phase II Hepatocellular Carcinoma Therapy Trial
How Have Hepatocellular Carcinoma Treatments Improved?
Neoadjuvant Immunotherapy for Resectable Hepatocellular Carcinoma
Perioperative Opdivo Alone, in Combination with Yervoy, Safe for Patients with HCC
Phase III Trial of Cabozantinib and Atezolizumab vs Sorafenib in Advanced Hepatocellular Carcinoma
Elevar Therapeutics and Hengrui Pharma Announce Camrelizumab Plus Rivoceranib Significantly Prolonged Overall Survival and Progression-Free Survival in Patients With Unresectable Hepatocellular Carcinoma (Phase III Trial)
New Study Shows Options for Older Patients With Liver Cancer
Cancer Burden Facing Asian Americans Partly Caused By Racism